Singapore: Glioblastoma multiforme (GBM) therapeutics market in Asia-Pacific (APAC) is estimated to grow double from USD...
The US scientists have created a promising second-generation antibiotic to fight against the bacteria that commonly caus...
Singapore: Valacyclovir, a drug indicated to control the virus that causes genital herpes, appears to reduce the levels ...
Singapore: The US Food and Drug Administration (FDA) has approved US-based ViiV Healthcare's single dose Triumeq tablet...
Singapore: A team of scientists at National University of Singapore (NUS) have discovered that a drug originally designe...
Singapore: Abivax, a leading clinical stage biotech company developing and commercializing anti-viral compounds and huma...
Singapore: Japan-based Eisai recieved US FDA approval for the US supply of the epilepsy drug Fycompa (perampanel) from i...
Singapore: Johnson & Johnson (J&J) is contemplating the thought of treating depression using popular street drug...
Singapore: Impax laboratories in Taiwan recently announced that FDA had delayed its decision on Rytary, the first non-ge...
Singapore: Hironic, based out of Seoul, Korea, is an innovator of medical aesthetic laser and energy devices. The compan...
The Global Health Innovative Technology Fund (GHIT Fund) of Japan, which in the last two years has funded almost $32 mil...
Singapore: ASLAN Pharmaceuticals, Singapore based biotech company focused on the development of immunotherapies and targ...
Singapore: A team from A*STAR's Institute of Chemical and Engineering Sciences (ICES) and National University Hospital (...
Singapore: Novartis Pharma KK has found no evidence that data on clinical trials for its hypertension drug Diovan had be...
Singapore: Boehringer Ingelheim and Eli Lilly's investigational Type 2 Diabetes (T2D) drug dipeptidyl peptidase-4 (DPP-4...
Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch ...
Singapore: Australian drug delivery company, Phosphagenics, has raised $11.45 million of its $15.29 million capital rais...
Singapore: Patrys, Australia's clinical stage biopharmaceutical company, has received approval to progress its phase I/I...
